INAB · Company research
IN8bio, Inc. (INAB): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
19records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| IN8bio Share Price - INAB, RNS News, Articles, Quotes, & Charts (NASDAQ:INAB) - Proactive financial news | IN8bio Share Price - INAB, RNS News, Articles, Quotes, & Charts (NASDAQ:INAB) Proactive financial news | View source ↗ | Proactive financial news | Oct 13, 2026 | neutral | 0 | 0.6 |
| IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | IN8bio, Inc. (Nasdaq: INAB) announced that its Compensation Committee granted a new employee nonqualified stock options to purchase 60,000 shares of common stock as an inducement to join the company. The options vest over four years with 25% vesting on the first anniversary and the remainder in equal monthly installments thereafter. | View source ↗ | GlobeNewswire Inc. | Oct 6, 2026 | neutral | 0 | 1 |
| IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | IN8bio, Inc. (Nasdaq: INAB) announced that its Compensation Committee granted a new employee nonqualified stock options to purchase 60,000 shares of common stock as an inducement to join the company. The options vest over four years with 25% vesting on the first anniversary and the remainder in equal monthly installments thereafter. | View source ↗ | GlobeNewswire Inc. | Oct 6, 2026 | neutral | 0 | 1 |
| A new hire’s right to buy IN8bio shares begins after one year. - Stock Titan | A new hire’s right to buy IN8bio shares begins after one year. Stock Titan | View source ↗ | Stock Titan | Oct 6, 2026 | neutral | 0 | 0.6 |
| IN8bio (INAB) Closes Flat at $1.40 as Shares Consolidate Between $1.33 Support and $1.47 Resistance - Time Weighted Price - https://www.dars.gov.et/ | IN8bio (INAB) Closes Flat at $1.40 as Shares Consolidate Between $1.33 Support and $1.47 Resistance - Time Weighted Price https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Oct 5, 2026 | neutral | 0 | 0.6 |
| IN8bio (INAB) Stock Analysis: Climbs +9.02%, Eyes on $1.52 2026-10-01 - Spring Pattern - https://www.dars.gov.et/ | IN8bio (INAB) Stock Analysis: Climbs +9.02%, Eyes on $1.52 2026-10-01 - Spring Pattern https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Oct 1, 2026 | neutral | 0 | 0.6 |
| IN8bio (INAB) Stock Analysis: Climbs +9.02%, Eyes on $1.52 2026-10-01 - Volume Spike Alerts - https://www.siam.in/ | IN8bio (INAB) Stock Analysis: Climbs +9.02%, Eyes on $1.52 2026-10-01 - Volume Spike Alerts https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Oct 1, 2026 | neutral | 0 | 0.6 |
| A drug developer will present cancer and autoimmune therapies Sept. 24 - Stock Titan | A drug developer will present cancer and autoimmune therapies Sept. 24 Stock Titan | View source ↗ | Stock Titan | Sep 22, 2026 | neutral | 0 | 0.6 |
| IN8bio CEO William Ho will speak at a Sept. 14 investor conference - Stock Titan | IN8bio CEO William Ho will speak at a Sept. 14 investor conference Stock Titan | View source ↗ | Stock Titan | Sep 10, 2026 | neutral | 0 | 0.6 |
| A drug developer with 20 years’ experience joins IN8bio - Stock Titan | A drug developer with 20 years’ experience joins IN8bio Stock Titan | View source ↗ | Stock Titan | Sep 9, 2026 | neutral | 0 | 0.6 |
| IN8bio (INAB): Posts a 5.79% Gain to $1.28 in the Latest Reading; Level Watch: Price Remains Between $1.22 Support and $1.34 Resistance in Latest Trading - Box Spread - siam.in | IN8bio (INAB): Posts a 5.79% Gain to $1.28 in the Latest Reading; Level Watch: Price Remains Between $1.22 Support and $1.34 Resistance in Latest Trading - Box Spread siam.in | View source ↗ | siam.in | Aug 22, 2026 | neutral | 0 | 0.6 |
| IN8bio (INAB): Posts a 5.79% Gain to $1.28 in the Latest Reading; Level Watch: Price Remains Between $1.22 Support and $1.34 Resistance in Latest Trading - Single Stock ETF - dars.gov.et | IN8bio (INAB): Posts a 5.79% Gain to $1.28 in the Latest Reading; Level Watch: Price Remains Between $1.22 Support and $1.34 Resistance in Latest Trading - Single Stock ETF dars.gov.et | View source ↗ | dars.gov.et | Aug 22, 2026 | neutral | 0 | 0.6 |
| INAB Forecast — Price Target — Prediction for 2027 - TradingView | INAB Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| IN8bio (INAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance | IN8bio (INAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now Yahoo Finance | View source ↗ | Yahoo Finance | Jun 4, 2026 | neutral | 0 | 0.6 |
| Guatemala Reports 38% Forest Coverage Nationwide - Latina Republic | Guatemala Reports 38% Forest Coverage Nationwide Latina Republic | View source ↗ | Latina Republic | Dec 22, 2025 | neutral | 0 | 0.6 |
| IN8bio (INAB) Stock Forecast and Price Target 2026 - MarketBeat | IN8bio (INAB) Stock Forecast and Price Target 2026 MarketBeat | View source ↗ | MarketBeat | May 11, 2024 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Mar 26, 2024 | neutral | 0 | 0.6 |
| What is the current Price Target and Forecast for IN8bio (INAB) - Zacks Investment Research | What is the current Price Target and Forecast for IN8bio (INAB) Zacks Investment Research | View source ↗ | Zacks Investment Research | Aug 12, 2022 | neutral | 0 | 0.6 |
| IN8bio, Inc. (INAB) Stock Price, News, Quote & History - Yahoo! Finance Canada | IN8bio, Inc. (INAB) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Nov 14, 2020 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.